Device Trial Radar · NCT00486226
The Registry to Study Safety and Performance of the CORDIS Vascular Reconstruction Device and Delivery System
Last checked: Nov 20, 2026Latest source record: Dec 12, 2018 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
105
Actual
Start
Jun 1, 2007
Primary completion
Dec 1, 2012
Study completion Dec 1, 2013
Sponsor
- Lead sponsor
- Codman & ShurtleffNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 14, 2007
Design
- Study type
- Observational
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The objective of the registry is to evaluate the real world safety and performance of the CORDIS ENTERPRISE™ Vascular Reconstruction Device and Delivery System (VRD) to facilitate endovascular coil embolization of intracranial aneurysms.
Conditions
- Intracranial Aneurysm
Interventions
Vascular Reconstruction DeviceDevice
CORDIS ENTERPRISE™ VRD
Primary outcomes
What the sponsor says the trial is designed to measure.
- The Successful Intracranial VRD Placement With Satisfactory Coil Mass Position Without the Occurrence of Any Device and/or Procedure Related Serious Adverse Event (SAE)Time frame: Intra-procedure
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Université Libre de Bruxelles
Brussels, Belgium
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.